SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-22-019570
Filing Date
2022-10-14
Accepted
2022-10-14 16:02:59
Documents
19
Period of Report
2022-12-06

Document Format Files

Seq Description Document Type Size
1 PRE 14A 2023_pre_14a.htm PRE 14A 1829489
2 GRAPHIC img85672898_0.jpg GRAPHIC 1478
3 GRAPHIC img85672898_1.jpg GRAPHIC 677
4 GRAPHIC img85672898_2.jpg GRAPHIC 782
5 GRAPHIC img85672898_3.jpg GRAPHIC 677
6 GRAPHIC img85672898_4.jpg GRAPHIC 782
7 GRAPHIC img85672898_5.jpg GRAPHIC 776
8 GRAPHIC img85672898_6.jpg GRAPHIC 677
9 GRAPHIC img85672898_7.jpg GRAPHIC 677
10 GRAPHIC img85672898_8.jpg GRAPHIC 677
11 GRAPHIC img85672898_9.jpg GRAPHIC 677
12 GRAPHIC img85672898_10.jpg GRAPHIC 677
13 GRAPHIC img85672898_11.jpg GRAPHIC 677
14 GRAPHIC img85672898_12.jpg GRAPHIC 677
15 GRAPHIC img85672898_13.jpg GRAPHIC 677
16 GRAPHIC img85672898_14.jpg GRAPHIC 782
17 GRAPHIC img85672898_15.jpg GRAPHIC 776
18 GRAPHIC img85672898_16.jpg GRAPHIC 829222
19 GRAPHIC img85672898_17.jpg GRAPHIC 323185
  Complete submission text file 0000950170-22-019570.txt   3242209
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRE 14A | Act: 34 | File No.: 000-50484 | Film No.: 221311350
SIC: 2834 Pharmaceutical Preparations